You are here

  • Home
  • Archive
  • Volume 6, Issue Suppl 1
  • 245 Associations between patient acceptable symptom stateand three domains of the disease in SLE: a cross-sectional study of 1,364 patients from the spanish society of rheumatology lupus registry

Article Text

Article menu

Download PDFPDF

Abstracts
245 Associations between patient acceptable symptom stateand three domains of the disease in SLE: a cross-sectional study of 1,364 patients from the spanish society of rheumatology lupus registry
Free
  1. Tomas R Vazquez Rodriguez1,
  2. Iñigo Rua Figueroa2,
  3. Victor Del Campo Perez3,
  4. Javier Narváez-García4,
  5. Francisco Javier López-Longo5,
  6. Maria Galindo Izquierdo6,
  7. Jaime Calvo Alen7,
  8. Antonio Fernandez Nebro8,
  9. Juan Ovalles-Bonilla5,
  10. Paula Rubio Muñoz9,
  11. Eva Tomero Muriel10,
  12. Coral Mouriño Rodriguez3,
  13. Esther Uriarte Isacelaya11,
  14. Angela Pecondón Español12,
  15. Mercedes Freire González13,
  16. Ricardo Blanco Alonso14,
  17. Marian Gantes Mora15,
  18. Monica Ibañez Barcelo16,
  19. Carlos Montilla Morales17 and
  20. Jose Maria Pego Reigosa3
  1. 1Hospital Universitario Lucus Augusti
  2. 2Hospital de Gran Canaria DR. Negrín
  3. 3Complexo hospitalario Universitario Vigo
  4. 4Hospital de Bellvitge
  5. 5Hospital General Universitario Gregorio Marañón
  6. 6Hospital Universitario 12 de Octubre
  7. 7Hospital Universitario Araba
  8. 8UGC de Reumatología, Instituto de Investigación Biomédica de Málaga (IBIMA) Hospital Regional Universitario de Málaga, Spain
  9. 9Hospital Germans Trias I Pujol
  10. 10Hospital de la Princesa
  11. 11Hospital de Donostia
  12. 12Hospital Miguel Servet
  13. 13Hospital Juan Canalejo A Coruña (CHUAC)
  14. 14Hospital Marques de Valdecilla
  15. 15Hospital Universitario de Canarias
  16. 16Hospital Son Llàtzer de Palma de Mallorca
  17. 17Hospital Clinico Universitario Salamanca

Abstract

Background In a large cohort of systemic lupus erythematosus (SLE) patients, to evaluate the association between a Patient Acceptable Symptom State (PASS) and three different domains of the disease: activity, damage and impact of SLE on patients lives.

Methods Cross-sectional study of 1,364 SLE (ACR 97 Criteria) patients from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Patients were clinically assessed by the physicians, who collected data about demographics, clinical manifestations, laboratory features and therapies. SLE activity was assessed by using the SLEDAI (SLE Disease Activity Index). The Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI) was used to measure damage accrual. The impact of SLE on patients lives was evaluated by using the Lupus Impact Tracker (LIT). Finally, the PASS question ‘Considering all the different ways your disease is affecting you, if you would stay in this state for the next months, do you consider that your current state is satisfactory? was answered in a dichotomized way: yes/no. Measures of central tendency and spread were used to describe responses and T-test was used to evaluate the independence between PASS and the other questionnaires and indices.

Results Mean age (years)±S.D. of the 1364 patients included in the study was 49.9±13.3; 90.3% were female and 94.9% were Caucasian. In the total of patients, 979 (71.8%) were in PASS. Patients in PASS had significantly lower activity (SLEDAI Score) than those not in PASS (2.4±3.2 vs. 3.0±3.9, respectively; p=0.007). The SLICC/ACR DI was significantly lower in the group of patients in PASS compared to those without PASS (0.64±1.1 vs. 0.81±0.21, respectively; p=0.022). SLE had a significantly lower impact on patients in PASS in comparison to those without PASS (LIT Score: 8.47±7.5 vs. 19.8±8.34, respectively; p=0.001). Distribution and statistics for each group are shown in table 1.

View this table:
Abstract 245 Table 1

Conclusions In the largest observational European Registry of SLE patients, PASS was associated with other domains of the disease: activity, damage and impact on patients life. PASS is a simple and reliable patient-reported outcome that can be a useful tool to evaluate patients well-being.

Funding Source(s): None

https://doi.org/10.1136/lupus-2019-lsm.245

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.